DARNITSA
LIVE

Serial Number

79275945

Owner

Zahorii Hlib Volodymyrovych

Attorney

Kenneth Motolenich-Salas

Filing Date

Jun 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

DARNITSA Trademark

Serial Number: 79275945 • Registration: 6242068

DARNITSA is a trademark filed by Zahorii Hlib Volodymyrovych on June 11, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Zahorii Hlib Volodymyrovych (3 trademarks)

13 Boryspilska Street

Entity Type: 01

PRIVATE JOINT STOCK COMPANY “PHARMACEUTICAL FIRM "DARNITSA" (2 trademarks)

13 Boryspilska Street

Entity Type: 99

Trademark Details

Filing Date

June 11, 2019

Registration Date

January 12, 2021

Published for Opposition

October 27, 2020

Goods & Services

Antiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; Dietetic foods and beverages adapted for medical use; dietetic foods adapted for medical purposes; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; Capsules sold empty for pharmaceuticals; medicinal preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Drugs for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medicinal drinks; medicinal oils; medicated toiletry preparations; medicated shampoos; ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions and antibiotic ointments; teeth filling material; medicinal alcohol; food supplements; medical dressings; nutritional supplements; Pre-filled syringes containing pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Air purifying preparations; food for babies; protein dietary supplements; Tissues impregnated with pharmaceutical lotions for treating dermatological conditions; Alcohol for pharmaceutical purposes; stem cells for medical purposes; transplants, namely, surgical implants comprising living tissue used in transplant operations; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ferments for pharmaceutical purposes; phytotherapy preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical preparations for medical purposes for the diagnosis of pregnancy; Chemical preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical reagents for medical or veterinary purposes; surgical glues; surgical dressings; candy, medicated; candy for medical purposes; sanitary preparations for medical purposes; plasters for medical purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 12, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 28, 2025 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 3, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2023 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Apr 13, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 13, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 12, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 12, 2021 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2020 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 27, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 27, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Oct 25, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 7, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 7, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 7, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 21, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 21, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 21, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 21, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2020 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2020 TEME
ASSIGNED TO LIE
Sep 3, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2020 TROA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 28, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 13, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 13, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 14, 2020 RFCR
APPLICATION FILING RECEIPT MAILED
Jan 14, 2020 MAFR
NON-FINAL ACTION WRITTEN
Jan 13, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 9, 2020 REPR